Refresh

Fresenius Kabi Oncology Ltd. - Research Center

532545 FKONCO Group (B) BSE data
Back to Company

Results

Statement

More

Half Yearly results in brief
(Rs crore)
Sep ' 13 Mar ' 13 Sep ' 12 Mar ' 12 Sep ' 11

Sales

223.01 298.28 298.02 250.11 274.20

Operating profit

-20.40 72.66 70.34 27.50 41.69

Interest

2.64 -9.79 7.19 7.50 7.31

Gross profit

-22.18 83.27 64.13 20.55 35.22

EPS (Rs)

-2.53 2.57 2.53 0.40 3.50
Half yearly  results in details
Sep ' 13 Mar ' 13 Sep ' 12 Mar ' 12 Sep ' 11

Other income

0.86 0.82 0.98 0.54 0.85

Stock adjustment

-6.52 -15.69 -15.33 -6.37 12.39

Raw material

70.63 80.59 111.14 105.66 100.40

Power and fuel

- - - - -

Employee expenses

35.59 34.56 35.76 32.13 28.85

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

50.04 57.21 37.82 31.61 12.18

Expenses capitalised

- - - - -

Other expenses

93.68 68.94 58.29 59.58 78.70

Provisions made

- - - - -

Depreciation

14.44 13.22 12.56 12.31 11.66

Taxation

3.37 22.64 11.58 4.70 5.47

Net profit / loss

-39.99 40.60 39.99 6.28 55.31

Extra ordinary item

- -6.81 - 2.75 37.21

Prior year adjustments

- - - - -

Equity capital

15.82 15.82 15.82 15.82 15.82

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

300.63 300.63 158.23 158.23 158.23

Agg.of non promotoholding (%)

19.00 19.00 10.00 10.00 10.00

OPM (%)

-9.15 24.36 23.60 11.00 15.20

GPM (%)

-9.91 27.84 21.45 8.20 12.80

NPM (%)

-17.86 13.57 13.37 2.51 20.11
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com